Alpha Tau to Attend Jefferies Global Healthcare Conference in London
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 11 2025
0mins
Source: Globenewswire
CFO Participation: Alpha Tau Medical's CFO, Raphi Levy, will attend the Jefferies Global Healthcare Conference in London on November 18-19, 2025, for 1x1 investor meetings.
Company Overview: Alpha Tau Medical, founded in 2016, specializes in oncology therapeutics and is focused on the development and commercialization of the Alpha DaRT technology for treating solid tumors.
Alpha DaRT Technology: Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) utilizes radium-224 to deliver targeted alpha radiation directly to tumors, aiming to destroy cancer cells while minimizing damage to surrounding healthy tissue.
Contact Information: For investor relations inquiries, interested parties can reach out to Alpha Tau Medical at IR@alphatau.com.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
